Muscarinic receptor subtypes in human and rabbit bladder
Michael R. Ruggieri, Donald C. Bode, Robert M. Levin, Alan J. Wein
Abstract
Michael R. Ruggieri, Donald C. Bode, Robert M. Levin, Alan J. Wein
Abstract
Abstract Subtypes of muscarinic receptors have been proposed by several investigators, based on differences in the potency of muscarinic agonists in various tissues. Development of selective muscarinic agonists and antagonists for the urinary bladder would be extremely useful since side effects of the presently used drugs often limit their clinical usefulness. Direct investigation of muscarinic receptor subtypes by radioligand binding techniques has recently become possible. The muscarinic antagonist pirenzepine distinguishes between a high affinity and low affinity binding site in several tissues. Results of the present investigation indicate that only the low affinity pirenzepine binding site is present in both human and rabbit bladder. Muscarinic receptor linked biochemical responses (increased phosphatidyl inositol turnover and inhibition of adenyl cyclase) were also consistent with the presence of only the low affinity pirenzepine binding receptor subtype in both human and rabbit bladder.
OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Subtypes of muscarinic receptors have been proposed by several investigators, based on differences in the potency of muscarinic agonists in various tissues. Development of selective muscarinic agonists and antagonists for the urinary bladder would be extremely useful since side effects of the presently used drugs often limit their clinical usefulness. Direct investigation of muscarinic receptor subtypes by radioligand binding techniques has recently become possible. The muscarinic antagonist pirenzepine distinguishes between a high affinity and low affinity binding site in several tissues. Results of the present investigation indicate that only the low affinity pirenzepine binding site is present in both human and rabbit bladder. Muscarinic receptor linked biochemical responses (increased phosphatidyl inositol turnover and inhibition of adenyl cyclase) were also consistent with the presence of only the low affinity pirenzepine binding receptor subtype in both human and rabbit bladder.
Key concepts: Pirenzepine, Muscarinic acetylcholine receptor, Muscarinic acetylcholine receptor M1, Muscarinic antagonist, Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2, Receptor, Muscarinic acetylcholine receptor M4